Bristol Myers Squibb to Present at J.P. Morgan’s 40th Annual Healthcare Conference
04 Janeiro 2022 - 8:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will present at J.P. Morgan’s 40th Annual Virtual
Healthcare Conference on Monday, January 10, 2022. Giovanni
Caforio, M.D., Board Chair and Chief Executive Officer will make a
formal presentation and answer questions about the company at 7:30
a.m. ET.
The event will be webcast simultaneously at
http://investor.bms.com with materials related to the presentation
available at the start of the live webcast. A replay and archived
edition of the presentation will be available following the
event.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220104005013/en/
Bristol Myers Squibb Media: media@bms.com Investor
Relations: Tim Power 609-252-7509 timothy.power@bms.com Nina
Goworek 908-673-9711 nina.goworek@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
